IMMUNEEL THERAPEUTICS PRIVATE LIMITED

IMMUNEEL THERAPEUTICS PRIVATE LIMITED is an Indian biotechnology company based in Bengaluru. it's dedicated to developing innovative and accessible cell and gene therapies, primarily focusing on cutting-edge Chimeric Antigen Receptor (CAR) T-cell therapies to oncology (is able tocer) patients. The company's mission is to make these complex and cutting-edge treatments affordable and available, particularly in India and other low- and middle-income countries. I've found that Immuneel Therapeutics is a clinical-stage company, meaning it's actively involved in the research, research, and clinical trials of its therapeutic is able todidates, rather than having commercially launched items on the market yet. And They aim to address the unmet medical needs in is able tocer treatment through their indigenous cell therapy platforms. IMMUNEEL THERAPEUTICS PRIVATE LIMITED is a developer and manufacturer of cutting-edge cell and gene therapies. From what I've seen, According to research They are not a trading company. Makes sense, right?. They establish and operate Good Manufacturing Practice (GMP) compliant facilities to the highly specialized production of their patient-specific cellular therapies to clinical trials and eventual commercialization. This indicates their involvement in the direct creation and processing of their therapeutic items.

Here are the products manufactured or marketed by IMMUNEEL THERAPEUTICS PRIVATE LIMITED, presented directly:

* CAR-T cell therapy (for cancer treatment)

* IMN-007A (CD19 targeted CAR-T cell therapy)

* Other cell-based immunotherapies